news
Fermented chondroitin sulfate shows better absorption for joint health
A new fermentation-derived chondroitin sulfate, MyCondro™, shows better plasma concentration than animal-derived versions in pharmacokinetic data. Two placebo-controlled trials at 600 mg daily support its efficacy for joint health and active aging. This addresses issues with raw material variability and sustainability in the supplement industry.
A new fermentation-derived chondroitin sulfate, MyCondro™, shows better plasma concentration than animal-derived versions in pharmacokinetic data. Two placebo-controlled trials at 600 mg daily support its efficacy for joint health and active aging. This addresses issues with raw material variability and sustainability in the supplement industry.
The architecture take
The joint health supplement market is still largely run on animal products, which is a problem for traceability and for anyone who wants to avoid animal inputs. So when a brand like MyCondro™ comes out with a fermented chondroitin that actually shows better uptake in the body, that's a signal. The pharmacokinetic data here suggests better absorption than standard animal-derived chondroitin, which is the whole point of taking a supplement. You want the stuff to get where it needs to go. This isn't just about offering a vegan alternative; it's about making a more effective product that clears the supply chain hurdles, too. It means formulators can ditch the animal sourcing headaches and still give consumers something that works. I'm watching to see how this impacts ingredient sourcing for other brands in the space, and how quickly it replaces the older forms.